NEW YORK (GenomeWeb) – Wells Fargo Securities on Thursday initiated coverage of molecular diagnostics firms Foundation Medicine, Myriad Genetics, and Genomic Health, noting each firm has sustainable competitive advantages over the long term.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.
The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.
The first Reproducibility Project: Cancer Biology papers show mixed results.
In Nature this week: mobile phone-based targeted DNA sequencing, and more.